Vaccine Adjuvants

Preparation Methods and Research Protocols

Editors:

ISBN: 978-0-89603-735-9 (Print) 978-1-59259-083-4 (Online)

Table of contents (20 protocols)

  1. Front Matter

    Pages i-x

  2. No Access

    Book Protocol

    Pages 1-27

    An Overview of Adjuvant Use

  3. No Access

    Book Protocol

    Pages 29-48

    Harmful and Beneficial Activities of Immunological Adjuvants

  4. No Access

    Book Protocol

    Pages 49-63

    Freund's Adjuvants

  5. No Access

    Book Protocol

    Pages 65-89

    Aluminum Compounds as Vaccine Adjuvants

  6. No Access

    Book Protocol

    Pages 91-103

    Poly(Lactide-Coglycolide) Microparticles As Vaccine Adjuvants

  7. No Access

    Book Protocol

    Pages 105-119

    Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants

  8. No Access

    Book Protocol

    Pages 121-136

    Aqueous Formulation of Adjuvant-Active Nonionic Block Copolymers

  9. No Access

    Book Protocol

    Pages 137-150

    Liposomes As Immunological Adjuvants and Vaccine Carriers

  10. No Access

    Book Protocol

    Pages 151-178

    Immunopotentiating Reconstituted Influenza Virosomes (IRIVs)

  11. No Access

    Book Protocol

    Pages 179-196

    Cochleates for Induction of Mucosal and Systemic Immune Responses

  12. No Access

    Book Protocol

    Pages 197-209

    Virus-like Particles As Vaccine Adjuvants

  13. No Access

    Book Protocol

    Pages 211-228

    The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan,

  14. No Access

    Book Protocol

    Pages 229-237

    Preparation of the Syntex Adjuvant Formulation (SAF, SAF-m, and SAF-1)

  15. No Access

    Book Protocol

    Pages 239-258

    The ISCOM™ Technology

  16. No Access

    Book Protocol

    Pages 259-271

    QS-21 Adjuvant

  17. No Access

    Book Protocol

    Pages 273-282

    MPL® Immunostimulant: Adjuvant Formulations

  18. No Access

    Book Protocol

    Pages 283-297

    Cytokines As Vaccine Adjuvants: The Use of Interleukin-2

  19. No Access

    Book Protocol

    Pages 299-313

    DNA As an Adjuvant

  20. No Access

    Book Protocol

    Pages 315-326

    Transcutaneous Immunization

  21. No Access

    Book Protocol

    Pages 327-336

    Mutant Heat-Labile Entertoxins As Adjuvants for CTL Induction

  22. Back Matter

    Pages 337-342